Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: A single center experience [7]

Leukemia and Lymphoma

Volumn 48, Issue 4, 2007, Pages 823-826

  Edeline, Veronique ^a   Bonardel, Gerald ^b   Brisse, Herve ^a   Foehrenbach, Herve ^b   Pacquement, Helene ^a   Maszelin, Philippe ^b   Gaillard, Jean François ^b   Michon, Jean ^a   Neuenschwander, Sylvia ^a  

^a INSTITUT CURIE   (France)

^b University of Paris Descartes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIAZEPAM; FLUORODEOXYGLUCOSE F 18;

ADJUVANT THERAPY; ADOLESCENT; B CELL LYMPHOMA; CANCER REGRESSION; CANCER RELAPSE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LETTER; MEDIASTINUM TUMOR; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; WHOLE BODY CT;

ADOLESCENT; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MEDIASTINAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34247241086     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601162854     Document Type: Letter

References (13)

1. Pastore, G., Magnani, C., Verdecchia, A., Pession, A., Viscomi, S. and Coebergh, J. W. (2001) Survival of childhood lymphoma in Europe, 1978-1992: A report from the EUROCARE study. Eur J Cancer, 37, pp. 703-710.
2. Radford, J. A., Cowan, R. A. and Flanagan, M. (1998) The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol, 6, pp. 940-946.
3. Luker, G. D. and Siegel, M. J. (1993) Mediastinal Hodgkin disease in children: Response to therapy. Radiology, 189, pp. 737-740.
4. Borgwardt, L., Larsen, H. J., Pedersen, K. and Hojgaard, L. (2003) Practical use and implementation of PET in children in a hospital PET center. Eur J Nucl Med Mol Imaging, 30, pp. 1389-1397.
5. Yeung, H., Grewal, R. K., Gonen, M., Schoder, H. and Larson, S. M. (2003) Patterns of (18)F-FDG uptake in adipose tissue and muscle: A potential source of false-positives for PET. J Nucl Med, 44, pp. 1789-1796.
6. Depas, G., De Barsy, C., Jerusalem, G., Hoyoux, C., Dresse, M. F. and Fassotte, M. F. (2005) 18F-FDG PET in children with lymphomas. Eur J Nucl Mol Imaging, 32, pp. 31-38.
7. Hernandez-Pampaloni, M., Takalkar, A., Yu, J. Q., Zhuang, H. and Alavi, A. (2006) F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol, 36, pp. 524-531.
8. Kaste, S. C., Howard, S. C., McCarville, E. B., Krasin, M. J., Kogos, P. G. and Hudson, M. M. (2005) 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol, 35, pp. 141-154.
9. Brink, I., Reinhardt, M. J., Hoegerle, S., Altehoefer, C., Moser, E. and Nitzsche, E. U. (2001) Increased metabolic activity in the thymus gland studied with 18F-FDG PET: Age dependency and frequency after chemotherapy. J Nucl Med, 42, pp. 591-595.
10. Weinblatt, M. E., Zanzi, I., Belakhlef, A., Babchyck, B. and Kochen, J. (1997) False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease. J Nucl Med, 38, pp. 888-890.
11. Kawano, T., Suzuki, A. and Ishida (2004) The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy. Eur J Nucl Med Mol Imaging, 31, pp. 831-836.
12. Shin, M. S. and Ho, K. J. (1983) Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease. An immunologic rebound phenomenon?. Cancer, 51, pp. 30-33.
13. Asad, S., Aquino, S. L., Piyavisetpat, N. and Fischman, A. J. (2004) False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. Am J Roentgenol, 182, pp. 983-989.